Navigation Links
Insmed To Present At JMP Securities 7th Annual Healthcare Conference
Date:7/10/2012

MONMOUTH JUNCTION, N.J., July 10, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung, today announced that Renu Gupta, M.D., Executive Vice President of Development and Chief Medical Officer, will be presenting a corporate overview at the JMP Securities 7th Annual Healthcare Conference in New York on Thursday, July 12, 2012, at 2:00 PM ET.

A live audio webcast will be made available on Insmed's website, http://www.insmed.com.  The webcast will also be archived for 90 days.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, our estimates regarding our capital requirements and our needs for additional financing, our ability to access additional funds under the Hercules loan agreement, results of operations, the status and the results of pre-clinical studies and clinical trials and pre-clinical and clinical data described herein, the timing of and costs associated with pre-clinical studies and clinical trials, the development of our products, our estimates of the size of the potential markets for our product candidates, and the business strategies, plans and objectives of management, c
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
2. Insmed Announces First Quarter 2012 Financial Results
3. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
4. Insmed to Host 2012 First Quarter Earnings Conference Call
5. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
6. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
7. Delcath To Present At JMP Securities Healthcare Conference On July 12
8. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
9. PLC Systems To Present At OneMedForum In New York City
10. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
11. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
(Date:7/30/2014)... and PARIS , July 30, 2014 ... and Sanofi (EURONEXT: SAN and NYSE: SNY ... trials of alirocumab in people with hypercholesterolemia met their ... baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks ... investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ...
(Date:7/30/2014)... , July 30, 2014  DigiPath, Inc. (OTCBB ... is expanding into the cannabis testing and education markets, ... its business and affairs not previously disclosed or, to ... recent unusual market action. "We have noticed ... the last three trading days," said Steve Barbee ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... Jan. 5, 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 study with ISIS-TTRRx.  The results demonstrated ... reductions of greater than 80 percent in transthyretin ... well tolerated with no significant adverse events.  ISIS-TTRRx ...
... (NASDAQ: AMRI ), a global contract services ... preferred provider agreement with BioPontis Alliance LLC. The agreement ... gap between early-stage research and technologies being discovered and ... provide its services in small molecule discovery, development, and ...
Cached Medicine Technology:ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 2ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 3ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 4AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
(Date:7/30/2014)... July 30, 2014 Calling all runners in ... to announce it will host a monthly Runner’s Injury ... 2231 Old Brick Road the second Monday of each month ... 8, October 13, November 10 and December 8. , ... Participants, who should wear running shoes and attire, will receive ...
(Date:7/30/2014)... CareSource, a nonprofit, Ohio-based health plan, ... CEO, Wright-Patt Credit Union, to the CareSource Ohio Board ... CEO with an extensive background in leading credit unions. ... chief operating officer at Wright-Patt Credit Union (WPCU) in ... Wright-Patt Credit Union that has realized more than seven ...
(Date:7/30/2014)... July 30, 2014 Park Cities ... instituted company-wide staff meetings this month to reinforce best ... Ms. White chose to institute the meetings when ... and amongst staff has become over the past decade. ... her business that allow for quicker processing of customer ...
(Date:7/30/2014)... of traumatic events experienced during deployment, returning National ... drinking problem if faced with civilian life setbacks, ... financial and legal problemsall commonplace in military families. ... University,s Mailman School of Public Health are published ... Medicine . , Alcohol abuse is a major ...
(Date:7/30/2014)... who are born with severe combined immunodeficiency (SCID) can ... cells, according to experts led by Memorial Sloan Kettering,s ... development of transplant protocols. Their review will be published ... England Journal of Medicine . , SCID is a ... to severely malfunction. When this breakdown occurs, babies no ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 2Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 4Health News:Vets' alcohol problems linked to stress on the home front 2Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2
... Wis. , March 15 National Alliance of ... Association,s Institute for Quality and Patient Safety and the New ... they are sponsoring an initiative to expand the number of ... Jersey Wound Care Certification Initiative. This new initiative was borne ...
... FORT WORTH, Texas , March 15 ... a growing  provider of specialty medical products, announced today ... the DFCon 10 Global Diabetic Foot Conference in ... is more than 1000 physicians, clinicians, researchers, scientists, and ...
... naltrexone improves odds of not drinking, researchers say , ... the antidepressant Zoloft (sertraline) and the alcoholism drug naltrexone ... and alcohol dependence will be able to stop drinking, ... patients found that 54 percent of those who received ...
... A potent new inhibitor of HIV, derived from bananas, ... transmission of HIV, according to a University of Michigan Medical ... emerging interest in lectins, naturally occurring chemicals in plants, because ... leads to a variety of infections. In laboratory ...
... HONG KONG , March 15 /PRNewswire-Asia/ -- ... Code: 801), China,s leading,integrated healthcare device and ... shareholders (the "Shareholders") have approved at an,Extraordinary General Meeting ... the board of directors ("the Board") to change the ...
... nurse specialist at the Christiana Care Breast Center at the Helen F. Graham Cancer Center, is the 2010 recipient of the Pearl Moore Making a Difference Award from the ... ... ... ...
Cached Medicine News:Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 2Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 3Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 4Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 5Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 2Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 3Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 4Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 5Health News:University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection 2Health News:Golden Meditech Shareholders Approves of Name Change 2Health News:Golden Meditech Shareholders Approves of Name Change 3Health News:Christiana Care Health System's Darcy Burbage Receives Oncology Nursing Society Award 2Health News:Christiana Care Health System's Darcy Burbage Receives Oncology Nursing Society Award 3
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
... internal calibration mass for convenient ... of Fully Automatic Self-Calibration at ... changes are detected, or touch-key ... RS232 Interface, Shimadzu WindowsDirect communication ...
Medicine Products: